BioVAT-HF Phase 1/2 Reveals First Evidence for Effective
Featured Late Breaking Clinical Science presentation at American Heart Association Scientific Sessions in PhiladelphiaSafe Maximal Dose Confirmed with...
Source: globenewswire.com
Featured Science News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Featured Science. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Featured Science Today - Breaking & Trending Today
Milestone Pharmaceuticals Presents Positive Results from ReVeRA Phase 2 Study of Etripamil in AFib-RVR at the American Heart Association Scientific Sessions 2023
Etripamil, an investigational drug, showed statistically significant reduction in ventricular rate by 30 beats per minute for episodes of atrial fibrillation with rapid ventricular rate compared to...
Source: marketscreener.com
Milestone Pharmaceuticals Announces Etripamil AFib-RVR Study is Selected for Featured Science Presentation at the American Heart Association Scientific Sessions 2023
/PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today announced that results from a double-blind, randomized, placebo-controlled Phase 2...
Source: prnewswire.com
Rapidly Optimize HF Meds After Hospital Discharge: STRONG-HF
Outcomes were superior with a 'high-intensity' uptitration strategy compared with usual care, but questions about implementation in practice remain.
Source: medscape.com
AHA 2022 to Recapture In-Person Vibe but Preserve Global Reach
Planners see the meeting's Chicago return as a hybrid after 2 years relegated to cyberspace as a chance for first impressions on some just entering the field.
Source: medscape.com